Can Platelet-Rich Plasma (PRP) Spread Cancer?

PRP has not been shown to cause cancer or make it spread in people who have been treated with it, including cancer survivors.1PubMed Central. Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients2PubMed. Medical Concerns in Orthobiologics Procedures The worry isn’t baseless, though. The healing signals PRP delivers are the same kind tumours use to grow. So the real question is less whether PRP is dangerous in general and more when and where it should be used if cancer is in the picture.

What Happened When Cancer Patients Got PRP

The best human evidence comes from breast cancer survivors. Scars from chemotherapy ports and wounds after lymph node surgery can heal slowly or poorly, and PRP is used to help wounds close. In 89 breast cancer patients who had PRP on scars from their chemotherapy port, no cancer came back in the treated scar.3PubMed Central. Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients Those patients also went about as long without the cancer returning near the original site as those who didn’t get PRP, roughly six years on average in both groups.4PubMed Central. Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients The same held for cancer spreading elsewhere in the body, with about the same time free of spread in both groups.5PubMed Central. Platelet-rich plasma (PRP) in oncological patients: long-term oncological outcome analysis of the treatment of subcutaneous venous access device scars in 89 breast cancer patients

A second study looked at PRP used during surgery. In 163 breast cancer patients who had PRP during lymph node surgery, no one in either group had recurrence, spread or death over 2.5 years.6PubMed Central. Platelet-Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies In these patients, PRP did not seem to make their cancer worse.

Wider reviews agree. Reviews of PRP and similar treatments for joints and tendons have found no increased risk of cancer.7PubMed. Medical Concerns in Orthobiologics Procedures Most of this evidence, though, comes from small groups of breast cancer patients followed for a few years, so it is reassuring but not final. A study of a few hundred people can miss a small increase in risk, and some cancers return much later than a few years of follow-up can show.

If your cancer was a different type, such as melanoma, prostate or a blood cancer, these studies say little about you. Different cancers respond to growth signals in different ways, so reassurance in one type doesn’t automatically carry over. The evidence is thinner for you, which doesn’t mean PRP is harmful.

Why PRP Raises a Cancer Question at All

PRP is made by spinning your own blood to concentrate the platelets. Platelets release growth factors, natural signals that tell tissue to repair and grow. Activated platelets let out a burst of these signals at once, and some stay high for about six days.8PubMed. Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation The signals strongly boost the growth of blood-vessel cells, about 20-fold in lab dishes.9PubMed. Effects of calcium and thrombin on growth factor release from platelet concentrates: kinetics and regulation of endothelial cell proliferation That matters because new blood vessels are how healing tissue gets fed, and PRP triggers their growth in lab and animal tests.10PubMed. Platelet-rich plasma releasate promotes angiogenesis in vitro and in vivo

Tumours have the same need. Both a healing wound and a growing tumour require new vessels to bring in oxygen and nutrients. A signal that helps repair tissue isn’t harmful by nature, but cells that are already growing abnormally can borrow it.

In lab dishes, PRP’s growth signals made breast cancer cells multiply faster.11PubMed Central. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review In mice with implanted human breast cancer, signals rich in blood-vessel growth factors made tumours grow larger.12PubMed Central. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review In some breast cancer cell types, PRP switched on changes linked to spreading.13PubMed Central. Interface between breast cancer cells and the tumor microenvironment using platelet-rich plasma to promote tumor angiogenesis – influence of platelets and fibrin bundles on the behavior of breast tumor cells And in bone cancer cells, PRP made cells move more and change behaviour.14PubMed. Platelet-rich plasma induces mixed osteogenic/osteoclastogenic phenotype in osteosarcoma SaOS-2 cells: role of TGF-beta15PubMed. Platelet-rich plasma stimulates cytokine expression and alkaline phosphatase activity in osteoblast-derived osteosarcoma cells

These results don’t translate directly to people. Cells in a dish have no immune system and no surrounding tissue holding them in check, so they can respond more freely than they would in a body. In the mouse studies the tumours were exposed directly to platelet products, which is very different from an injection elsewhere. A PRP injection into a knee or scalp is usually far from any tumour, so these findings explain caution near tumours rather than a general danger. The concern is placing PRP’s concentrated burst of signals right next to cancer cells that could respond to it.

Some Lab Studies Show the Opposite

PRP doesn’t always help cancer cells. In one lab study, it lowered breast cancer cell survival and reduced their ability to move and invade.16PubMed Central. Platelet-Rich Plasma Inhibits Breast Cancer Proliferation It was toxic to bladder cancer cells in lab dishes, alone or with a standard bladder cancer drug.17PubMed. Effects of intravesical therapy with platelet-rich plasma (PRP) and Bacillus Calmette-Guérin (BCG) in non-muscle invasive bladder cancer In rats with bladder tumours, 70% of those treated with PRP plus that drug did better than with the drug alone.18PubMed Central. What is the potential use of platelet-rich-plasma (PRP) in cancer treatment? A mini review

How PRP affects cancer seems to depend on the cancer type and how the PRP is prepared, which is why no simple yes or no exists. Clinics use different spinning methods and platelet concentrations, so one clinic’s PRP isn’t the same product as another’s. How the platelets are activated changes how fast their signals are released.

None of this makes PRP a cancer treatment. The anti-cancer results are early lab and animal findings, and no one should use PRP in place of oncology care. If you’re interested in PRP as a cancer therapy, ask your oncologist about clinical trials rather than clinics selling it.

When PRP Is and Isn’t Recommended With a Cancer History

Expert consensus rules for PRP in people with a cancer history depend on where the injection goes and the state of the cancer:

Remission means your oncologist sees no active disease after treatment, but the cancer may still return. Cured usually means a long stretch of years without return, depending on the cancer type. Your oncologist, not the PRP clinic, decides which category you are in.

These rules were written for joint and tendon injections, but similar caution appears elsewhere. Studies of PRP for erection problems excluded men with active or spread cancer.24The Journal of Sexual Medicine. 146 The Efficacy of Platelet-Rich Plasma (PRP) as a Supplemental Therapy for the Treatment of Erectile Dysfunction (ED): Initial Outcomes For cancer survivors seeking cosmetic care, PRP is counted among the lowest-risk options.25Dermatologic Therapy. Aesthetic Medicine Procedures in Oncology Patients: A Safety‐Based Clinical Framework for Restorative Oncodermatology

Where the injection goes matters too. A knee injection far from a past breast cancer is a different situation from a scalp treatment near a skin cancer. Tell the clinic about any lumps or lesions near the area.

Blood cancers and some blood disorders can change how platelets work or how many there are. PRP made from affected blood may not behave like PRP from healthy blood, so its effects are less predictable. If you have one of these conditions, discuss PRP with your haematologist before agreeing to treatment.

Questions to Ask Before Getting PRP

Start with your oncologist. Ask which of the categories above you fall into. Then tell the PRP provider your full cancer history, including whether it spread and any treatment you’re on now. Ask how they prepare and activate the PRP, since that changes how the signals are released.26PubMed. Platelet concentrates: effects of calcium and thrombin on endothelial cell proliferation and growth factor release Finally, check that the area to be injected is free of any unexplained lump or growth.

A careful clinic asks about your cancer history before booking treatment, not just on a form you sign at the door. It delays or refuses treatment if your cancer is active. It asks for written clearance from your oncologist when your history calls for it, and it explains honestly what the evidence does and doesn’t show.

Some signs should end the conversation. Claims that PRP can treat or prevent cancer go beyond any evidence. A clinic that waves away your cancer history as irrelevant isn’t following the guidance for survivors. Pressure to book repeat sessions without reviewing how the first one went is a sales tactic, not careful care.

Afterward, keep up your regular cancer check-ups as usual and report any new lump near the injection site. The usual PRP side effects are soreness, swelling and bruising.

How PRP Compares With Stem Cell Treatments

Stem cell therapies carry their own tumour concerns. Adult stem cells carry less tumour risk than embryonic-type stem cells, but uncontrolled growth is a known concern.27PubMed Central. Critical Appraisal of Evidence on Platelet-Refresh Plasma and Stem Cell Therapy for Stress Urinary Incontinence: A Narrative Review Stem cells are living cells that can multiply. PRP is cell fragments from your own blood, with no cells that can divide into a tumour. Its worry is concentrated signals feeding cancer that is already there, not the treatment forming new growths.

The two can be hard to tell apart in a clinic. Many offer both under the label “regenerative medicine,” so they can look like one service. PRP is not stem cells, whatever the marketing implies. Because PRP comes from your own blood, rejection risk is low, and infection is uncommon with sterile technique. Stem cell products often have weaker evidence and looser regulation than PRP, so ask exactly what will be injected, where it comes from, and what evidence supports it.